CDK2 and prostate carcinoma: Since experiments for elucidating the involvement of Cdk1 and Cdk2 in promoting NED were performed only in AR-positive prostate cancer cell lines, investigating the AR-negative cell lines might shed more light in proposed role of Cdk1 and Cdk2 deregulation in promoting NED.